ASTRAL- a Clinical Study to Assess the Efficacy and Toxicity of High-dose Chemotherapy

Clinical trial NCT04121507 · COMPLETED

Trial details

NCT number: NCT04121507
Sponsor: GWT-TUD GmbH
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Aggressive Non-hodgkin Lymphoma (aNHL)Lymphoma, B-Cell Lymphoma, T-Cell

Start date: 2019-06-24
Primary completion: 2022-03-30
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.